• EdU Imaging Kits (Cy3) for CCA Proliferation

  2026-09-28

  EdU Imaging Kits (Cy3) convert S-phase DNA synthesis into a bright, denaturation-free Cy3 signal for microscopy or flow cytometry. The workflow provides a practical orthogonal readout for testing paeoniflorigenone, cisplatin, and HIF1A-linked proliferation changes in cholangiocarcinoma models.

• IPR-803 and the Case for Tumor-Stroma Reprogramming

  2026-09-28

  IPR-803 offers a mechanistic way to interrogate uPAR–uPA signaling in tumor invasion—and, in a recent pancreatic cancer nanomedicine study, to explore how that pathway could be integrated with stromal remodeling and chemotherapy. This article connects the compound’s biochemical profile to practical translational decisions while distinguishing preclinical promise from clinical evidence.

• Ciprofloxacin Research: Workflows and Applications

  2026-09-27

  Ciprofloxacin supports both established bacterial susceptibility workflows and emerging nanotheranostic research, but the experimental questions and controls differ sharply between these settings. This practical guide covers handling, assay planning, ultrasound-enabled ZIF-8 studies, and common sources of variability without treating preclinical cancer findings as clinical evidence.

• Annexin V-FITC/PI Apoptosis Assay Kit Workflow

  2026-09-26

  The Annexin V-FITC/PI Apoptosis Assay Kit provides a two-color method to distinguish viable cells from cells with phosphatidylserine exposure or compromised membranes. It is intended for research workflows such as flow cytometry and fluorescence microscopy, not for diagnostic use; its readout alone cannot reliably distinguish late apoptosis from necrosis.

• Trigeminal Compression, Neuroinflammation, and Piezo2

  2026-09-25

  A rat model of trigeminal root compression links peripheral neuroinflammation with mechanical allodynia through a Ca²⁺-dependent CGRP/SP–Piezo2 pathway. The study combines behavioral, tissue-level, and in vitro evidence to outline a proposed sensitization loop, while leaving its relevance to human trigeminal neuralgia and its relationship to other signaling pathways open for testing.

• AL-8810 in FP-Receptor Assay Design

  2026-09-25

  Learn how AL-8810 (SKU B4575) can help researchers distinguish FP-receptor-dependent signaling from changes in cell viability, proliferation, or cytotoxicity readouts. The guide combines product-reported potency and handling details with a 2024 endometrial study and practical assay-design considerations.

• CCCP as a Mitochondrial Stress-Test in Translation

  2026-09-24

  CCCP can provide a controlled way to perturb mitochondrial energetics, but its value in translational research depends on separating an acute experimental challenge from disease biology. We connect its mechanism to a urine-derived stem cell imaging study in Alzheimer’s research and outline practical safeguards for interpreting morphology assays.

• Vorinostat: From HDAC Inhibition to Translational Insight

  2026-09-24

  Vorinostat offers a practical way to interrogate how HDAC inhibition reshapes gene expression and cell fate. This article connects its mechanism to experimental design and to emerging neuroblastoma findings, while clarifying what comparative preclinical evidence can—and cannot—tell translational researchers.

• Camostat Mesilate for Reliable Cell Assays

  2026-09-23

  Learn how to use Camostat Mesilate (SKU B2082) to investigate protease-linked signaling while interpreting cell viability and cytotoxicity results carefully. This scenario-driven guide covers assay controls, formulation, dosing, fibrosis-related readouts, and practical product-selection criteria.

• Ciprofloxacin Beyond Bacteria: A Nanomedicine Case Study

  2026-09-23

  Ciprofloxacin is best known as a fluoroquinolone antibiotic, but recent nanomedicine research shows how its physicochemical and redox-related properties can be repurposed in an ultrasound-responsive cancer platform. This article translates that finding into practical assay, formulation, and interpretation decisions without conflating antibacterial and antitumor mechanisms.

• Measuring Cancer Drug Response Beyond Viability

  2026-09-22

  Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent dimensions of anticancer drug response. The framework supports better assay interpretation by pairing these measurements across time rather than treating a single viability endpoint as a complete pharmacologic description.

• Afatinib in Patient-Derived Gastric Cancer Assembloids

  2026-09-22

  A translational framework for using Afatinib, also known as BIBW 2992, to distinguish tumor-intrinsic ErbB dependence from stromal modulation in patient-derived gastric cancer assembloids.

• Mc-Val-Cit-PABC-PNP ADC Linker Protocol

  2026-09-21

  Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC peptide linker for antibody-drug conjugate synthesis workflows that require a lysosomal payload-release design. It is suited to DMSO-compatible research handling, but its water and ethanol insolubility makes it unsuitable for aqueous formulations, diagnostic use, or clinical and therapeutic applications.

• NamiRNA Dual-Pathway Control in Pancreatic Cancer

  2026-09-21

  Yu et al. show that miR-200c suppresses pancreatic cancer through two mechanistically distinct routes: nuclear activation of PTPN6 transcription through an enhancer and post-transcriptional repression of CDH17. LNP delivery extended these findings into a preclinical therapeutic model, while the study design provides a framework for separating proliferation, migration, enhancer activity, and delivery effects.

• Faropenem Sodium: Translational Leverage in AMR

  2026-09-20

  Faropenem sodium offers translational researchers a distinctive way to connect penem-mediated cell wall disruption with renal transporter biology, antimicrobial susceptibility, and resistance-focused experimental design. This article examines the mechanistic evidence, practical workflow considerations, competitive positioning, and limitations that determine its value in advanced infection research.

8316 records 1/555 page Next 12345 下5页 Last page